Cite
HARVARD Citation
Alberer, M. et al. (2017). Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet. 390 (10101), pp. 1511-1520. [Online].